Published August 17, 2026Updated October 30, 2026

The Real Cost of Wegovy: Insurance, GoodRx, and Manufacturer Coupons Compared

How much does Wegovy actually cost in 2026? We break down list price, insurance co-pays, NovoCare self-pay, the Novo Nordisk savings card (for plans that cover Wegovy), GoodRx, and compounded alternatives side by side.

By Nora Bissett, Pricing Editor

Our methodology sets out how these guides get researched and kept current.

Looking for a provider? Our 2026 comparison of the leading GLP-1 telehealth sellers is a click away.

Savings Calculator →

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

Wegovy's list price is $1,349.02 per 28-day supply. Almost nobody pays that, but the price you will pay is maddeningly hard to predict because it depends on your insurance plan, your employer's formulary, your state's pharmacy discount rules, and whether you qualify for the manufacturer's savings card or self-pay price. Below is every pricing path, with real numbers, and which ones are worth pursuing.

If you already know your insurance won't cover weight-loss drugs and you want the fastest answer, our GLP-1 savings calculator will estimate your monthly cost based on your insurance type and preferred medication.

Key Takeaways

  • List price: $1,349.02 per package (Novo Nordisk, 2026)
  • With commercial insurance that covers Wegovy: your plan's co-pay after prior authorization, as little as $25/month with the savings card
  • With no Wegovy coverage, or paying cash: Novo Nordisk's self-pay price is $149–$299/month for the pill and $349/month for the pen ($399 for 7.2 mg)
  • With Medicare: Part D plans may cover it for the cardiovascular indication; for weight management, the temporary Medicare GLP-1 Bridge charges $50/month to patients who qualify
  • GoodRx for Wegovy: rarely useful; prices sit close to list
  • Compounded semaglutide: $129–$249/month with no insurance hassle
  • Annual cost range: $300 (best insurance) to $16,188 (full list price)

The Headline Number: $1,349.02

Novo Nordisk's published list price ("wholesale acquisition cost" or WAC) for Wegovy is $1,349.02 per 28-day supply, which works out to roughly $16,188 per year if you pay list for 12 months. This is the price before any insurance, discount card, or manufacturer program is applied.

Dose makes no difference to list price. A pen box costs the same at 2.4 mg as it does at 1.7 mg, 1.0 mg, 0.5 mg or 0.25 mg. That's a deliberate manufacturer pricing strategy. It means a patient in month 1 (starting dose) and month 8 (maintenance dose) both pay the same retail price.

Verify the current price directly on Wegovy.com. Prices change often.

Path 1: Commercial Insurance That Covers Wegovy

If your employer-sponsored or marketplace insurance plan includes Wegovy on its formulary for obesity treatment, you'll typically pay a tiered co-pay after meeting any deductible. Typical ranges:

Path 1: Commercial Insurance That Covers Wegovy
Plan typeMonthly co-pay range
Preferred brand (Tier 2)$25 – $50
Non-preferred brand (Tier 3)$60 – $150
Specialty tier (Tier 4)$150 – $350
High-deductible plan, pre-deductibleFull list price until deductible met

The catch: almost every plan that covers Wegovy requires prior authorization (PA). Typical PA criteria include:

  • BMI at ≥30, or ≥27 with a documented comorbidity (dyslipidemia, sleep apnea, hypertension or type 2 diabetes)
  • Documentation of a prior structured weight-loss attempt (often 6 months of diet and exercise notes)
  • No contraindications (thyroid cancer history, pancreatitis, etc.)
  • Reauthorization every 6–12 months with documented weight loss

For details on which insurers cover Wegovy and how to navigate the PA process, see our state-by-state insurance breakdown or the research article on GLP-1 coverage across commercial plans, Medicaid and Medicare.

Path 2: Commercial Insurance That Does NOT Cover Wegovy

This is the most common situation in 2026: many commercial plans still exclude GLP-1 drugs when prescribed for obesity. The Wegovy Savings Card does not help here, because it requires a plan that covers Wegovy. The option that does is Novo Nordisk's self-pay price.

Novo Nordisk Self-Pay (NovoCare Pharmacy)

Novo Nordisk sells Wegovy for cash to people whose insurance does not cover it or who choose to buy outside their plan:

Novo Nordisk Self-Pay (NovoCare Pharmacy)
Wegovy form and doseSelf-pay price per month
Pill, 1.5 mg$149
Pill, 4 mg$199
Pill, 9 mg or 25 mg$299
Pen, 0.25 mg to 2.4 mg$349
Pen, 0.25 mg or 0.5 mg, first 2 fills for new patients (through December 31, 2026)$199
Wegovy HD pen, 7.2 mg$399

Self-pay is bought outside your plan, so it does not count toward your deductible. Some telehealth sellers also sell brand Wegovy: Ro and Hims list the Wegovy pill from $149/month and the pen from $199/month, with their memberships billed separately.

The Wegovy Savings Card (if your plan covers Wegovy)

For commercially insured patients whose plan *does* cover Wegovy, the savings card can bring the cost down to as little as $25/month, with savings capped at $100/month. It requires commercial or private insurance (no Medicare, Medicaid, TRICARE, VA, or other government plans) and a prescription for an FDA-approved use.

We cover this and the Eli Lilly equivalent in detail in our manufacturer coupons guide.

Path 3: Medicare and Medicaid

Medicare Part D has kept weight-loss drugs out by statute for most of its history. Since 2024, after the SELECT cardiovascular indication, Part D plans have been allowed to cover Wegovy for patients with established cardiovascular disease together with obesity or overweight; coverage depends on the plan. For weight management, Part D patients who qualify can get Wegovy for $50/month under the Medicare GLP-1 Bridge, a temporary program (July 2026 through 2027) that requires prior authorization.

Medicaid coverage varies wildly by state. Some states cover Wegovy for obesity through their Medicaid programs, often with strict PA requirements, and some have pulled back: California and Pennsylvania ended adult weight-loss coverage on January 1, 2026. Others cover GLP-1s only for diabetes (meaning Ozempic only). We maintain a state-by-state list in our insurance coverage breakdown.

Path 4: GoodRx and Discount Cards (Mostly a Dead End)

GoodRx, SingleCare, and similar discount cards work well for generic drugs. They work poorly for brand-name GLP-1s. GoodRx prices for Wegovy typically sit close to list. The current GoodRx Wegovy page is worth checking, but don't expect miracles.

The structural reason: GoodRx negotiates with pharmacy benefit managers on cash-pay pharmacy rates. Those rates for brand-name GLP-1s sit close to list; the deep cash discounts come from the manufacturers' own self-pay programs instead. Compare this to a generic like metformin, where GoodRx can knock 80% off retail.

Bottom line: don't use GoodRx for Wegovy. Novo Nordisk's self-pay price, or the savings card if your plan covers Wegovy, is dramatically better.

Path 5: Compounded Semaglutide

Compounded semaglutide is the same active ingredient as Wegovy, prepared by state-licensed 503A pharmacies for individual patients and dispensed through telehealth providers. It's not "Wegovy" (it doesn't use Novo Nordisk's formulation, and it's not FDA-approved as a finished drug product), but the molecule is identical.

Typical monthly costs for compounded semaglutide from reputable providers:

Path 5: Compounded Semaglutide
ProviderTypical monthly cost
CoreAge Rx$79
Henry Meds$297
Mochi Health$139 ($79 membership + medication from $60)

See our full best GLP-1 providers ranking for up-to-date pricing and reviews. Before choosing compounded, read our safety explainer on compounded semaglutide, because not every compounder is reliable.

Putting It All Together: Annual Cost Scenarios

Putting It All Together: Annual Cost Scenarios
ScenarioMonthlyAnnual
Best case: insurance covers, $25 co-pay$25$300
Good case: insurance covers, $100 co-pay$100$1,200
NovoCare self-pay, Wegovy pill$149–$299$1,788 – $3,588
NovoCare self-pay, Wegovy pen$349$4,188
Compounded semaglutide via telehealth$129–$249$1,548 – $2,988
Full list price, no discounts$1,349$16,188

The spread is enormous. The same molecule can cost you $300/year or $16,000/year depending on how you access it.

Pros and Cons of Each Path

Insurance-covered Wegovy:

  • Pro: Cheapest option when it works; FDA-approved brand
  • Con: PA hassle; still unavailable for most plans; can be discontinued if you lose coverage

NovoCare self-pay ($149–$399/mo):

  • Pro: Brand-name drug, predictable pricing, no insurance needed
  • Con: Doesn't count toward your deductible; can cost more than compounded semaglutide

Compounded semaglutide:

  • Pro: Dramatically cheaper; fast telehealth access; no PA
  • Con: Not FDA-approved as finished product; quality varies by pharmacy; ongoing regulatory uncertainty

GoodRx / discount cards:

  • Pro: Worth a 30-second check
  • Con: Almost never meaningful for brand GLP-1s

How to Actually Navigate This

  1. Call your insurer first. Ask specifically: "Is Wegovy on my formulary for obesity treatment? What's the PA requirement? What's my tier and co-pay?"
  2. If covered: work with your prescriber to file the PA. Budget 2–4 weeks.
  3. If not covered: compare Novo Nordisk's self-pay prices at Wegovy.com.
  4. If you want a lower price point: compare compounded semaglutide providers in our best providers ranking.
  5. Always check real prices: use the live price tracker before committing.

Telehealth adds its own layer to these paths. eMed and Hello Alpha charge a monthly membership with the medication billed separately, and eMed's Wegovy program adds at-home blood tests. Form Health, a virtual obesity-medicine clinic, bills visits, labs and medication to insurance where it can.

Tomorrow lists Wegovy billed monthly, and Klinic prescribes Wegovy under its brand name and accepts most major insurance plans. Push Health writes brand-name prescriptions and routes them through its pharmacy network. Luvo Health lists brand Ozempic, and KairoRx charges an access fee for Ozempic with the drug billed separately. Elevated Health lists branded Ozempic beside its compounded plans.

Bottom Line

There is no single "Wegovy cost." It ranges from $300 a year to over $16,000 a year, and which end you land on depends almost entirely on the path you take. For most patients without generous GLP-1 coverage, the practical choice in 2026 is between Novo Nordisk's self-pay price ($149–$299/month for the pill, $349/month for the pen) and compounded semaglutide ($129–$249/month) from a reputable telehealth provider.

Before you commit, model your actual cost using our savings calculator and read our research breakdown of GLP-1 insurance coverage to understand which insurers and plan types typically cover Wegovy. For a deeper look at the related question of who covers Wegovy, read does insurance cover Wegovy.

Sources & methodology — as of October 2026
  1. 1.NovoCare — Wegovy cash-pay and savings program— Novo Nordisk (NovoCare).
  2. 2.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
  3. 3.KFF — Employer Health Benefits Annual Survey— Kaiser Family Foundation.
  4. 4.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  5. 5.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
  6. 6.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.

Ready to compare GLP-1 providers?

Trust, support, availability, the medications carried and what they cost — we rank every major telehealth seller on all five, and refresh it each quarter. Nothing padded.

Savings Calculator →

Read our methodology · affiliate disclosure · about us